探讨审方药师医嘱审核干预对不合理用药的影响

Exploring the influence of prescription reviewer's intervention in medical order review on unreasonable drug use

目的分析审方药师医嘱审核干预对不合理用药的影响。方法选择静配中心2021年117118份医嘱和2022年127747份医嘱进行分析,2021年未采取审方药师医嘱审核干预,2022年采取审方药师医嘱审核干预。比较2021、2022年静配中心不合理医嘱发生情况。结果2022年静配中心不合理医嘱发生率0.49%低于2021年的0.85%,差异具有统计学意义(P<0.05)。结论不合理医嘱主要为溶媒选择不当、溶媒量不适宜、给药剂量不适宜、给药频次不适宜、配伍不当等,审方药师通过对医嘱进行审核,采取有效措施对不合理用药情况进行干预,能够保证临床合理用药,保证患者用药安全性。

Objective To analyze the influence of prescription reviewer's intervention in medical order review on unreasonable drug use.Methods 117118 medical orders from pharmacy intravenous admixture services in 2021 and 127747 orders in 2022 were selected for analysis.In 2021,there was no prescription reviewer's intervention in medical order review,and in 2022,there was prescription reviewer's intervention in medical order review.The unreasonable medical orders in pharmacy intravenous admixture services in 2021 and 2022 were compared.Results The incidence of unreasonable medical orders in 2022 was 0.49%,which was lower than 0.85%in 2021,and the difference was statistically significant(P<0.05).Conclusion Unreasonable medical advice mainly includes improper selection of solvent,inappropriate solvent dosage,inappropriate dosage,inappropriate frequency of administration,and improper compatibility.By reviewing medical orders and taking effective measures to intervene in unreasonable drug use,pharmacists can ensure rational clinical medication and the safety of patient medication.